Star Scientific Advantages of smoking

Choosing only one star from our CAPS community and with investors there split on an even base between falling and upward trends on the company, you might suppose that Star Scientific is a stock most avoided. You could be right, but let’s not be hasty in generalization. Lets’ examine why you might prefer to buy, sell or hold Star Scientific, taking a look at particular tobacco concerns you might think over.

In accordance with its smart stock symbol, Star Scientific focuses in smokeless tobacco products and its technology intends to decrease the disastrous effects if tobacco. For those people who are trying to quit this addictive habit, it is of great interest. Probably one reason to buy the company is that, mostly in America smoking rate is slowly dropping. This affects traditional cigarette suppliers, while supporting the appeal of Star Scientifics’ proposals.

According to statistics between 1965 and 2007, the percentage of Americans smoking a pack of cigarette or even more per day decreased from 56% to 7%. Those lighting up between 10 and 20 cigarettes per day dropped from 11% to 5%. There are a lot of factors affecting the falling smoking rate, among which are increasing health concerns and rising tobacco taxes on tobacco products that have significantly lifted the prices over the years. Evidently, cigarette companies have been affected by the decrease in smoking, and want to share these findings.

Reynolds American underlines that the mean cost of a pack of cigarettes has increased significantly since 1998, rising from $2.09 to $5.86. The company representative also added that: “Since 1998, governments have collected more than $400 billion in cigarette taxes and other payments from smokers.” Reynolds’ profit has been rather flat within the past few years, as it tries to conquer a dropping domestic consumer base despite growing prices.

Altria, the largest tobacco producers with popular brands as Marlboro, has a lot of investors worrying that its most profitable years are behind it, and supposing that its world counterpart, Philip Morris International, keeps more promises as cigarette consumption is increasing faster abroad. Philip Morris also allows other benefits, as for instance it is better able to escape the kind of litigation expenses that affect domestic businesses. Two consecutive lawsuits resulted in a $119 million fourth-quarter charge for Altria. Some are speculating for the rise on the company because of its tobacco-derived dietary supplement known as Anatabloc, which has been outselling Star Scientific’s dissolvable smoking products.